These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6589222)

  • 1. Nifedipine treatment of Tourette's syndrome.
    Goldstein JA
    J Clin Psychiatry; 1984 Aug; 45(8):360. PubMed ID: 6589222
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine-haloperidol combination in the treatment of Gilles de la Tourette's syndrome: a case study.
    Alessi NE; Walden M; Hsieh PS
    J Clin Psychiatry; 1989 Mar; 50(3):103-4. PubMed ID: 2925592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol.
    Müller-Vahl KR; Schneider U; Kolbe H; Emrich HM
    Am J Psychiatry; 1999 Mar; 156(3):495. PubMed ID: 10080574
    [No Abstract]   [Full Text] [Related]  

  • 4. Risperidone as a treatment for Tourette's syndrome.
    Bruun RD; Budman CL
    J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists in the treatment of Tourette's disorder.
    Walsh TL; Lavenstein B; Licamele WL; Bronheim S; O'Leary J
    Am J Psychiatry; 1986 Nov; 143(11):1467-8. PubMed ID: 3465244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Tourette's syndrome with calcium antagonists.
    Micheli F; Gatto M; Lekhuniec E; Mangone C; Fernandez Pardal M; Pikielny R; Casas Parera I
    Clin Neuropharmacol; 1990 Feb; 13(1):77-83. PubMed ID: 2306750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives.
    Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ
    J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
    Peterson BS
    J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tourette's disorder.
    Barak Y; Szor H; Ring A; Sarova-Pinhas I; Lampl Y
    Isr J Psychiatry Relat Sci; 1994; 31(3):233-4. PubMed ID: 7868325
    [No Abstract]   [Full Text] [Related]  

  • 11. [Control of inner speech and Gilles de la Tourette's syndrome].
    Vercueil L
    Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tourette's syndrome: an expanded view.
    O'Quinn AN; Thompson RJ
    Pediatrics; 1980 Sep; 66(3):420-4. PubMed ID: 6932642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The course of Tourette's disorder: a literature review.
    Coffey BJ; Biederman J; Geller DA; Spencer T; Park KS; Shapiro SJ; Garfield SB
    Harv Rev Psychiatry; 2000 Oct; 8(4):192-8. PubMed ID: 11038344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tourette's disease: successful treatment.
    Bieren RE
    J S C Med Assoc; 1969 Jan; 65(1):7-8. PubMed ID: 5249506
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 cases of Gilles de la Tourette's disease treated with haloperidol decanoate].
    Paolucci S; Buttinelli C; Ciani S; Fiume S
    Minerva Psichiatr; 1982; 23(1):59-61. PubMed ID: 6954338
    [No Abstract]   [Full Text] [Related]  

  • 16. The central role of magnesium deficiency in Tourette's syndrome: causal relationships between magnesium deficiency, altered biochemical pathways and symptoms relating to Tourette's syndrome and several reported comorbid conditions.
    Grimaldi BL
    Med Hypotheses; 2002 Jan; 58(1):47-60. PubMed ID: 11863398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyproterone acetate treatment of Tourette's syndrome.
    Izmir M; Dursun SM
    Can J Psychiatry; 1999 Sep; 44(7):710-1. PubMed ID: 10500878
    [No Abstract]   [Full Text] [Related]  

  • 18. Gilles de la Tourette's syndrome: case report.
    Shenken LI
    N Z Med J; 1980 Sep; 92(668):234-5. PubMed ID: 6935542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tourette syndrome treated with nifedipine.
    Bhatia MS; Balkrishna ; Singhal PK; Kaur N
    Indian J Pediatr; 1989; 56(2):300-1. PubMed ID: 2807462
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gilles de la Tourette's syndrome].
    Buianov MI
    Med Sestra; 1981 Apr; 40(4):20-2. PubMed ID: 6941063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.